Catalent to Acquire Accucaps, Expanding Global Softgel Capability
Catalent Pharma Solutions has agreed to acquire Accucaps Industries Limited, the Canada-based developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels. The acquisition, which is subject to Canadian governmental approval, will substantially strengthen Catalent’s global softgel capabilities with the addition of a portfolio of OTC and prescription products supplied to the North American market.
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.
Explore The Range of Delivery Options for Your Molecule
This web tool enables drug development professionals to solve one of the most challenging aspects in drug development, determining the optimal finished dose suited to your specific product requirements, target indication and molecule properties.
Discover solutions to improve the value of your treatments at every clinical stage.
Easily browse 300+ proven consumer product formulas to find the technology you need.
Learn more about our tailored solutions for Consumer Health, Animal Health & Biologics.